BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26343485)

  • 1. Psychometric validation of the consensus five-factor model of the Positive and Negative Syndrome Scale.
    Fong TC; Ho RT; Wan AH; Siu PJ; Au-Yeung FS
    Compr Psychiatry; 2015 Oct; 62():204-8. PubMed ID: 26343485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An excitement subscale of the Positive and Negative Syndrome Scale.
    Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
    Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    J Psychiatr Res; 2016 Sep; 80():87-92. PubMed ID: 27318892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia.
    Rodriguez-Jimenez R; Bagney A; Mezquita L; Martinez-Gras I; Sanchez-Morla EM; Mesa N; Ibañez MI; Diez-Martin J; Jimenez-Arriero MA; Lobo A; Santos JL; Palomo T;
    Schizophr Res; 2013 Jan; 143(1):77-83. PubMed ID: 23201306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
    Peralta V; Cuesta MJ
    Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Persian version of the Calgary Depression Scale for Schizophrenia (CDSS-P).
    Rostami R; Kazemi R; Khodaie-Ardakani MR; Sohrabi L; Ghiasi S; Sadat Kamali Z; Zaryabi A; Ghiasi Z; Nasiri Z; Rezaei M; Addington DE
    Asian J Psychiatr; 2019 Oct; 45():44-49. PubMed ID: 31493624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor structure and external validity of the PANSS revisited.
    Van den Oord EJ; Rujescu D; Robles JR; Giegling I; Birrell C; Bukszár J; Murrelle L; Möller HJ; Middleton L; Muglia P
    Schizophr Res; 2006 Feb; 82(2-3):213-23. PubMed ID: 16229988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients.
    Fresán A; De la Fuente-Sandoval C; Loyzaga C; García-Anaya M; Meyenberg N; Nicolini H; Apiquian R
    Schizophr Res; 2005 Jan; 72(2-3):123-9. PubMed ID: 15560957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
    Loas G; Noisette C; Legrand A; Delahousse J
    Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the factor structure of symptoms in patients with schizophrenia.
    Kim JH; Kim SY; Lee J; Oh KJ; Kim YB; Cho ZH
    Psychiatry Res; 2012 May; 197(3):285-9. PubMed ID: 22364933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensional approaches to schizophrenia: A comparison of the Bern Psychopathology scale and the five-factor model of the Positive and Negative Syndrome Scale.
    Lang FU; Müller-Stierlin AS; Walther S; Stegmayer K; Becker T; Jäger M
    Psychiatry Res; 2016 May; 239():284-90. PubMed ID: 27043275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated five-factor model of positive and negative syndrome scale for schizophrenia in Chinese population.
    Jiang J; Sim K; Lee J
    Schizophr Res; 2013 Jan; 143(1):38-43. PubMed ID: 23148897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS).
    Lançon C; Auquier P; Nayt G; Reine G
    Schizophr Res; 2000 May; 42(3):231-9. PubMed ID: 10785581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.
    Eisenberg DP; Aniskin DB; White L; Stein JA; Harvey PD; Galynker II
    Psychopathology; 2009; 42(4):242-8. PubMed ID: 19451757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scales for assessment of depression in schizophrenia: Factor analysis of calgary depression rating scale and hamilton depression rating scale.
    Grover S; Sahoo S; Dua D; Chakrabarti S; Avasthi A
    Psychiatry Res; 2017 Jun; 252():333-339. PubMed ID: 28315621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Yoruba version of the Beck Hopelessness Scale: psychometric characteristics and correlates of hopelessness in a sample of Nigerian psychiatric outpatients.
    Aloba O; Akinsulore A; Mapayi B; Oloniniyi I; Mosaku K; Alimi T; Esan O
    Compr Psychiatry; 2015 Jan; 56():258-71. PubMed ID: 25446724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of depression with cognitive insight and socio-occupational outcome in patients with schizophrenia.
    Grover S; Sahoo S; Nehra R; Chakrabarti S; Avasthi A
    Int J Soc Psychiatry; 2017 May; 63(3):181-194. PubMed ID: 28162014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.